It will be a great pleasure to pitch for smartbax at the 8th #AMRconference in Basel. Come see us at Wednesday evening and looking forward to engaging with everyone during the conference! #AMR #INCATE #startup #pitching
Info
smartbax develops novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms. With the first-in-class compounds, the company targets the multi-drug resistant pathogens methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).
- Website
-
http://www.smartbax.de
Externer Link zu smartbax
- Branche
- Biotechnologieforschung
- Größe
- 2–10 Beschäftigte
- Hauptsitz
- München
- Art
- Privatunternehmen
- Gegründet
- 2021
Orte
-
Primär
Leopoldstr. 37
München, 80802, DE
Beschäftigte von smartbax
Updates
-
Hey there! Things are buzzing with activity this year. Join us at these upcoming events – we can't wait to connect with you! #AMR #smartbax #networking
-
We are thrilled to welcome Microbiologist Ana Patrícia Graça to the smartbax team through an Industry Placement Grant awarded by the Federation of European Microbiological Societies. Her expertise spans various areas, including mycobacterial metabolism, bioactivity of marine bacteria, compound extraction, and high-throughput screening assays against bacterial and fungal pathogens. Her multidisciplinary background significantly enhances our capabilities in the ongoing battle against AMR pathogens.
-
smartbax hat dies direkt geteilt
Das smartbax-Gründerteam hat sich dem Kampf gegen multiresistente Bakterien verschrieben. An seinem Standort in München erforscht das junge Unternehmen neue Strategien zur Entwicklung von Antibiotika und fokussiert sich dabei insbesondere auf den Ansatz, bakterielle Prozesse zu überaktivieren, die die Zellen zum Selbstverdau anregen. #antibiotika #startup #antibiotikaresistenzen #multiresistenz #keime
-
It's Pitching Time! Dear LinkedIn Community, Our CEO, Robert Macsics, will represent smartbax at the prestigious #FallingWalls competition in Berlin. Falling Walls: Breaking Down Scientific Barriers - For those who may not be familiar, Falling Walls is an international event that brings together some of the brightest minds in science and innovation. It's all about breaking down barriers and paving the way for groundbreaking discoveries. Robert Macsics has been selected to present our pioneering work in antibiotic development, focusing on new modes of action that address multiple unexploited targets. We are incredibly proud of this nomination and excited to present the science behind this remarkable project. We invite you to join us in celebrating this occasion. Please join us today, November 7th, at 2 PM for the live stream of session 3 at the following link: https://lnkd.in/d4r3qwND 🚀 Let's Cheer Robert On! 🚀 We are confident that he will do an outstanding job representing smartbax, and we hope you'll be there to show your support. Feel free to share this post with your network! Stay tuned for more updates and highlights from the Falling Walls competition. We can't wait to share our passion for science and innovation with all of you. #FallingWalls #ScienceInnovation #BiotechBreakthroughs Thank you for being a part of our journey and for your ongoing support!"
Falling Walls Venture Livestream | Science Summit 2023
falling-walls.com
-
News alert! Our team is thrilled to be a part of BIO-EUROPE right here in our hometown. If you're attending, come visit us at Hall B6 Booth #70, or simply say hello if you spot Robert Macsics, Sylvia Varland, and Eric Juskewitz. We can't wait to connect with you! #BIOEUROPE #AMR #smartbax
🔭 BIO-Europe is not far away! Don't miss Europe's largest 🤝 partnering event for the international #biotech and #pharma scene. We would like to introduce you our innovative biotech companies from #Bavaria and invite you to get in touch with them. Either use the super-comforting #partnering tool of BIO-Europe: ➡️ https://lnkd.in/gRkjn8M or drop by the Bavarian joint booth (hall B6, booth #70) to make first contacts and exchange ideas with the companies' representatives . Here on LinkedIn we will showcase our companies in the upcoming weeks. We kick off with: 👉 smartbax GmbH smartbax is developing a new generation of #antibiotics to address the increasing spread of multidrug-resistant bacteria. Their team works on innovative solutions focusing on substances that simultaneously address several targets, thus hindering resistance development in bacteria. 👉 OmicScouts GmbH is a chemical #proteomics company focused on supporting drug and #biomarkerdiscovery with its unique expertise and innovative technologies. They provide and develop proteome-wide assays that work with native proteins in a physiological setting and enable the identification of small molecule drug targets, target engagement #markers, molecular mechanisms of action and drug response biomarkers. 👉 #NDA Regulatory Service GmbH is an independent consulting group based in Germany, Sweden, Switzerland, United Kingdom and the USA. Its mission is to ensure that good medicines reach patients without unnecessary delay. It accomplishes this by providing the #pharmaceutical industry with a comprehensive range of professional drug development services focusing on #regulatoryaffairs, health technology assessment, #pharmacovigilance and #qualityassurance. 👉 leon-nanodrugs GmbH provides a leading technology for the encapsulation of nucleic acids, biomolecules, and other #APIs. Our technology solves your current encapsulation challenges. The company offers highly flexible #GMPmanufacturing solutions for your genetic payloads and other molecules, making manufacturing of transfection material a highly flexible and commercially viable proposition. LEON utilises its’ proprietary nano technology platform for the continuous manufacturing of SMART #nanoparticles (ranging from surface stablilised polymeric through to lipid nanoparticles (#LNP's) and liposomes). #BIOEurope #biotechinnovation #biopharma #drugdiscovery #drugdevelopment #technology #conference